Description: China Dasheng Biotechnology Company, formerly Max Nutrition Inc., was a retailer of health and wellness products, including vitamins, minerals, herbal, and specialty supplements, sports nutrition products, diet products and athletic sportswear. On January 29, 2008, pursuant to an agreement and plan of reorganization, (the Agreement) by and among the Company, Nicholas Stone and American Spring Pharmaceutical, Inc. (ASPI), ASPI purchased certain shares of the Company’s common stock and ASPI transfered of 100% interest in Gansu Biology Science and Technology Stock Co., Ltd (GDBS) to the Company. The Company is engaged in the production, marketing and distribution of bacteria-based products, which are used as additives for livestock feed and crop cultivation. GDBS owns an 80% interest in Lushen Bio-tech Co., Ltd (Lushen) and 60% interest in Elemiss Food Co., Ltd. (Elemiss).
Building B
Lanzhou,
China
Phone:
86 93 1844 1248
Officers
| Name | Title |
|---|---|
| Mr. Jinjun Qi | President & Secretary |
| Mr. Gang Chen | Chairman of the Board & CEO |
| Mr. Hongsheng Wang | Chief Financial Officer |
| Mr. Jingbo Gao | Vice President of Investor Relations |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Financials |
|---|---|
| GIC Group: | Financial Services |
| GIC Industry: | Capital Markets |
| GIC Sub-Industry: | Asset Management & Custody Banks |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.4681 |
| Price-to-Sales TTM: | 0.0978 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 689 |